Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway

Daejin Kim, Jae Wook Yang|Experimental and Therapeutic Medicine|2017

Cited by 11